If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Additional common side effects observed with Forteo® (teriparatide [rDNA origin] injection) treatment included (Forteo Package Insert, 2012):
Injection site reactions which may include redness, swelling, pain, itching, a few drops of blood, and bruising
Serious Adverse Events
Orthostatic hypotension with teriparatide therapy
Teriparatide may cause transient orthostatic hypotension (Forteo Package Insert, 2012).
Typically, an event began within 4 hours of dosing and spontaneously resolved within a few minutes to a few hours
Teriparatide should be administered initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur (Forteo Package Insert, 2012).
Serum calcium elevation with teriparatide therapy
Teriparatide may cause slight and transient increase in serum calcium (Forteo Package Insert, 2012).
Maximum concentrations are reached between 4 and 6 hours and return to baseline by 16 to 24 hours
Therefore, if blood samples for serum calcium are taken, it should be done at least 16 hours after the most recent teriparatide injection (Forteo Package Insert, 2012).
Enclosed Prescribing Information
The published references below are available upon request by contacting 1-800-LillyRx.
FORTEO® [Package Insert]. Indianapolis, IN: Eli Lilly and Company; 2012.
Date of Last Review: February 09, 2017